Xinxing Lai

发表

Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment

Danxi Li, Ying Gao, L. Tan, 2022, Frontiers in Neurology.

Efficacy and safety of LongShengZhi capsule on functional recovery after acute ischemic stroke (LONGAN): Protocol and statistical analysis plan for a randomized, double-blind, placebo-controlled trial

Anxin Wang, Li Zhou, Luda Feng, 2022, Frontiers in Pharmacology.

Platelet-activating factor receptor antagonists of natural origin for acute ischemic stroke: a systematic review of current evidence

Luda Feng, Dandan Zhang, Ying Gao, 2022, Frontiers in Pharmacology.

Edaravone use in acute intracerebral hemorrhage: A systematic review and meta-analysis of randomized controlled trials

Li Zhou, Luda Feng, Ying Gao, 2022, Frontiers in Pharmacology.

Efficacy and safety of Songling Xuemaikang capsule for essential hypertension: A systematic review and meta-analysis of randomized controlled trials.

Ying Gao, Qing-young He, K. Cao, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Trial of a prehospital intervention with traditional Chinese medicine for acute stroke (TRACE): Protocol for a mixed-methods research study

Ying Gao, Zi-yu Tian, Yanfang Liu, 2022, Frontiers in Pharmacology.

Clinical, laboratory and imaging predictors for critical illness and mortality in patients with COVID-19: protocol for a systematic review and meta-analysis

Luda Feng, Ying Gao, Tianyi Zhang, 2020, BMJ Open.

Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial

Ying Gao, K. Cao, Qiang Liu, 2017, Trials.

China Stroke Registry for Patients With Traditional Chinese Medicine (CASES-TCM): Rationale and Design of a Prospective, Multicenter, Observational Study

Chi Zhang, Luda Feng, Dandan Zhang, 2021, Frontiers in Pharmacology.

Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial

Xiaolong Wang, Yushan Chen, Wei Wu, 2022, Circulation. Cardiovascular quality and outcomes.

Multi-omics approaches for deciphering the complexity of traditional Chinese medicine syndromes in stroke: A systematic review

Xinxing Lai, Xuejiao Xiong, Ying Gao, 2022, Frontiers in Pharmacology.

Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment.

D. Wei, F. Liu, Xinxing Lai, 2023, Aging.

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis

Luda Feng, Tingting Liu, Ming-zhe Qin, 2023, Frontiers in Neurology.

Efficacy and safety of traditional Chinese medicine for acute ischemic stroke by resolving phlegm and unblocking fu-organs: A systematic review and meta-analysis.

Xinxing Lai, Sisong Cheng, Xiangyi Zheng, 2023, Journal of ethnopharmacology.